Henlius And Reddy’s Shake Hands On $130m Darzalex Biosimilar Deal
Licensing Agreement Covers US And Europe For Proposed Biosimilar To Mega-Blockbuster Daratumumab
Fresh from filing its proposed biosimilar to Perjeta with the US FDA, Henlius has brought in Dr Reddy’s Laboratories as its US and European commercial partner for its proposed biosimilar to Darzalex, which has already succeeded in Phase I trials.
